Identification of Potential Biomarkers of Depression and Network Pharmacology Approach to Investigate the Mechanism of Key Genes and Therapeutic Traditional Chinese Medicine in the Treatment of Depression

被引:8
|
作者
Shi, Yucong [1 ]
Chen, Dan [2 ]
Ma, Shengsuo [1 ]
Xu, Huachong [1 ]
Deng, Li [1 ]
机构
[1] Jinan Univ, Coll Tradit Chinese Med, Guangzhou 510632, Peoples R China
[2] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Dept Obstet & Gynecol, Wuhan 430014, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
DISEASE; P38; ANGIOGENESIS; QUERCETIN; ANXIETY; CANCER; BRAIN;
D O I
10.1155/2021/2165632
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. To explore the potential target of depression and the mechanism of related traditional Chinese medicine in the treatment of depression. Method. Differential gene expression in depression patients and controls was analyzed in the GEO database. Key genes for depression were obtained by searching the disease databases. The COREMINE Medical database was used to search for Chinese medicines corresponding to the key genes in the treatment of depression, and the network pharmacological analysis was performed on these Chinese medicines. Then, protein-protein interaction analysis was conducted. Prediction of gene phenotypes was based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment scores. Results. The total number of differentially expressed genes in the GEO database was 147. Combined with the GEO dataset and disease database, a total of 3533 depression-related genes were analyzed. After screening in COREMINE Medical, it was found that the top 4 traditional Chinese medicines with the highest frequency for depression were Paeonia lactiflora Pall., Crocus sativus L., Bupleurum chinense DC., and Cannabis sativa L. The compound target network consisted of 24 compounds and 138 corresponding targets, and the key targets involved PRKACA, NCOA2, PPARA, and so on. GO and KEGG analysis revealed that the most commonly used Chinese medicine could regulate multiple aspects of depression through these targets, related to metabolism, neuroendocrine function, and neuroimmunity. Prediction and analysis of protein-protein interactions resulted in the selection of nine hub genes (ESR1, HSP90AA1, JUN, MAPK1, MAPK14, MAPK8, RB1, RELA, and TP53). In addition, a total of four ingredients (petunidin, isorhamnetin, quercetin, and luteolin) from this Chinese medicine could act on these hub genes. Conclusions. Our research revealed the complicated antidepressant mechanism of the most commonly used Chinese medicines and also provided a rational strategy for revealing the complex composition and function of Chinese herbal formulas.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Pathogenesis of depression and the potential for traditional Chinese medicine treatment
    Ding, Weixing
    Wang, Lulu
    Li, Lei
    Li, Hongyan
    Wu, Jianfa
    Zhang, Jing
    Wang, Jing
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [2] Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods
    Xia, Zhiyu
    Gao, Peng
    Chen, Yu
    Shu, Lei
    Ye, Lei
    Cheng, Hongwei
    Dai, Xingliang
    Hu, Yangchun
    Wang, Zhongyong
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, : 1386 - 1405
  • [3] The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity
    Lv, Shimeng
    Yang, Ni
    Lu, Yitong
    Zhang, Guangheng
    Zhong, Xia
    Cui, Yaru
    Huang, Yufei
    Teng, Jing
    Sai, Yanyan
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [4] The therapeutic potential of traditional Chinese medicine in depression: Targeting adult hippocampal neurogenesis
    Feng, Lijin
    Xing, Hang
    Zhang, Kuo
    [J]. PHYTOMEDICINE, 2022, 98
  • [5] Venlafaxine. Pharmacology and therapeutic potential in the treatment of depression
    Burnett, FE
    Dinan, TG
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (03) : 153 - 162
  • [6] Challenge and Prospect of Traditional Chinese Medicine in Depression Treatment
    Zhang, Yuan-Wei
    Cheng, Yung-Chi
    [J]. FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [7] Network pharmacology -based study on the mechanism of traditional Chinese medicine in the treatment of glioblastoma multiforme
    Chen Liang
    Binbin Zhang
    Ruichun Li
    Shiwen Guo
    Xiaoxuan Fan
    [J]. BMC Complementary Medicine and Therapies, 23
  • [8] Network pharmacology -based study on the mechanism of traditional Chinese medicine in the treatment of glioblastoma multiforme
    Liang, Chen
    Zhang, Binbin
    Li, Ruichun
    Guo, Shiwen
    Fan, Xiaoxuan
    [J]. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [9] Network pharmacology: A new approach to unveiling Traditional Chinese Medicine
    WU Xiao-Ming
    WU Chun-Fu
    [J]. Chinese Journal of Natural Medicines, 2015, 13 (01) : 1 - 2
  • [10] Network pharmacology: A new approach to unveiling Traditional Chinese Medicine
    Wu Xiao-Ming
    Wu Chun-Fu
    [J]. CHINESE JOURNAL OF NATURAL MEDICINES, 2015, 13 (01) : 1 - 2